+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis



Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis



Journal of Affective Disorders 126(3): 335-348



To examine the validity of the Hospital Anxiety and Depression Scale (HADS) in the identification of psychiatric complications of cancer, as defined by a robust criterion standard. 50 analyses tested the depression subscale (HADS-D), anxiety subscale (HADS-A) or combined scales (HADS-T) against syndromal (clinical) depression (n=22), syndromal anxiety (n=4) or any mental ill health/distress (n=24), all defined by semi-structured psychiatric interview. The HADS and its subscales had both strengths and limitations. Overall it appeared to perform marginally better in non-palliative cancer settings. Specific findings for each subscale were as follows. In the identification of depression the HADS-T, HADS-D and HADS-A had a pooled sensitivity and specificity of 82.0%, 77.0%; 71.6%, 82.6% and 80.5%, 77.8%, respectively. All versions performed poorly in case-finding but well in a screening capacity. For anxiety there were no HADS-D studies. The HADS-T and HADS-A had a pooled sensitivity and specificity of 83.9%, 69.9% and 48.7%, 78.7%. They were poor at case-finding but good as screening instruments. For distress (any mental ill health) the HADS-T, HADS-D and HADS-A had a pooled sensitivity and specificity of 72.8%, 80.6%; 75.7%, 66.3% and 65.7%, 71.3%, respectively. When screening for distress and anxiety the HADS-T was the optimal subscale. For the identification of depression, anxiety or distress in cancer settings, the HADS (including subscales) is not recommended as a case-finding instrument but it may, subject to concerns about its length, be a suitable addition to screening programme.

(PDF emailed within 0-6 h: $19.90)

Accession: 052588146

Download citation: RISBibTeXText

PMID: 20207007

DOI: 10.1016/j.jad.2010.01.067


Related references

Diagnostic accuracy of the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses. Bmj Open 6(4): E011913, 2017

Reliability and validity of the Malayalam hospital anxiety and depression scale (HADS) in cancer patients. Indian Journal of Medical Research 122(5): 395-399, 2006

Limited validity of the Hospital Anxiety and Depression Scale (HADS) in dementia: evidence from a confirmatory factor analysis. International Journal of Geriatric Psychiatry 32(7): 805-813, 2016

Defining hospital anxiety and depression scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Annals of Oncology 22(10): 2330-2333, 2011

Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care?. Palliative Medicine 14(3): 219-220, 2000

What does the Hospital Anxiety and Depression Scale (HADS) Really Measure in Liaison Psychiatry Settings?. Current Psychiatry Reviews 1(1): 69-73, 2005

A Rasch analysis of the Hospital Anxiety and Depression Scale (HADS) among cancer survivors. Psychological Assessment 25(2): 379-390, 2014

Reliability and Validity of a Nepali-language Version of the Hospital Anxiety and Depression Scale (HADS). Kathmandu University Medical Journal 13(50): 115-124, 2016

The factorial structure and validity of the Hospital Anxiety and Depression Scale (HADS) in Polish adolescents. Psychiatria Polska 49(5): 1071-1088, 2016

Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). Bmc Psychiatry 12: 6, 2012

The validity and clinical utility of the hospital anxiety and depression scale (HADS) with older adult New Zealanders. International Psychogeriatrics 26(2): 325-333, 2014

Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients. Plos One 6(1): E16049, 2011

Personality traits, gender differences and symptoms of anhedonia: What does the Hospital Anxiety and Depression Scale (HADS) measure in nonclinical settings?. Scandinavian Journal of Psychology 57(2): 144-151, 2017

Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care and Research 63 Suppl 11: S454-S466, 2012

Use of the Hospital Anxiety and Depression Scale (HADS) in the assessment of depression in patients with inoperable lung cancer. Palliative Medicine 13(4): 353-354, 2000